InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
1.310
-0.020 (-1.50%)
At close: Sep 9, 2026, 4:00 PM EDT
1.290
-0.020 (-1.53%)
After-hours: Sep 9, 2026, 7:30 PM EDT
InMed Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
+285.22%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
13
Market Cap
5.85M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | - | - | - |
| Jun 30, 2025 | 4.94M | 344.90K | 7.50% |
| Jun 30, 2024 | 4.60M | 462.17K | 11.18% |
| Jun 30, 2023 | 4.14M | 3.05M | 279.61% |
| Jun 30, 2022 | 1.09M | - | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sunshine Biopharma | 35.35M |
| Sonoma Pharmaceuticals | 21.92M |
| cbdMD | 20.93M |
| China SXT Pharmaceuticals | 1.14M |
| Gelteq | 314.70K |
| RedHill Biopharma | 286.00K |
| Akanda | 258.08K |
| PRF Technologies | 31.00K |
INM News
- 10 hours ago - InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate Update - Newsfile Corp
- 7 weeks ago - Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline - PRNewsWire
- 2 months ago - InMed Pharmaceuticals amends merger pact with Mentari Therapeutics - TheFly
- 2 months ago - InMed Pharmaceuticals and Mentari Therapeutics Announce Amendment to Merger Agreement and Filing of Registration Statement on Form S-4 - Newsfile Corp
- 3 months ago - InMed regains compliance with Nasdaq continued listing requirements - TheFly
- 3 months ago - InMed Pharmaceuticals Regains Compliance with Nasdaq Continued Listing Requirements - Newsfile Corp
- 3 months ago - SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of InMed Pharmaceuticals, Inc. (Nasdaq – INM) - GlobeNewsWire
- 3 months ago - InMed Pharmaceuticals Transcript: M&A announcement - Transcripts